Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2008-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44bbc77d4711b754867573f7abfab498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28796a274cac2767751e6d8f7ccc1be5 |
publicationDate |
2013-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2426814-T3 |
titleOfInvention |
K-ras and B-raf mutations and anti-EGFr antibody therapy |
abstract |
Method of predicting whether a tumor will be insensitive to treatment with an antibody against EGFr, which comprises determining the presence or absence of a B-raf V600E mutation in a sample of said tumor; in which the presence of the B-raf mutation indicates that the tumor will be insensitive to treatment with the antibody against EGFr. |
priorityDate |
2007-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |